Instruments and medical devices · EYPT

EyePoint Pharmaceuticals, Inc.

12 filings mentioning 7 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
7topics disclosed
Instruments and medical devicesindustry
MAbased in

Across 12 filings we hold, EyePoint Pharmaceuticals, Inc. has written down 7 of the topics we track. That places it 9 of 36 companies we hold in instruments and medical devices, by how much we have collected.

EYPT Instruments and medical devices

What this obligates

Every instrument in our corpus that governs something EyePoint Pharmaceuticals, Inc. has written into a filing. Not what they said. What applies once they have said it.

ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ISO 37001:201639
GDPR26
ISO 3700126
ISO/IEC 27701:201921
Colorado Artificial Intelligence Act (proposed SB 24-205)16
EU AI Act15
Code of Conduct on Data Protection for Research (GDPR Article 40)12

10 frameworks, 299 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Internal Control9
Cross Border Data Transfer5
Data Residency5
Restatement2
Records Retention1
Enforcement Action1
Artificial Intelligence1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control92025-10-17
Cross Border Data Transfer52026-03-05
Data Residency52026-03-05
Restatement22020-08-05
Records Retention12020-11-06
Enforcement Action12023-05-18
Artificial Intelligence12026-07-17

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-07-178-KEntry into a material agreement, Financial statements and exhibitsfiling
2026-03-0510-Kfiling
2025-10-178-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2025-03-0610-Kfiling
2024-10-318-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2024-03-0810-Kfiling
2023-12-088-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2023-05-188-KEntry into a material agreement, Item 1.02, Completion of an acquisitionfiling
2023-03-1010-Kfiling
2022-03-1410-Kfiling
2021-02-038-KEntry into a material agreement, Financial statements and exhibitsfiling
2021-01-048-KEntry into a material agreement, Results of operations, the earnings release, Item 3.02filing

Others in instruments and medical devices

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
AEMDAETHLON MEDICAL INC12compare →
SCNDSCIENTIFIC INDUSTRIES INC12compare →
RVTYPERKINELMER INC12compare →
CTKBCytek Biosciences, Inc.12compare →
TXG10x Genomics, Inc.12compare →
AVTRAvantor, Inc.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of instruments and medical devices · All companies · Today's edition